Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,959 | -11,377 | -4,252 | -14,264 | -10,397 |
| Depreciation Amortization | 36 | 24 | 12 | 11 | 4 |
| Accounts payable and accrued liabilities | 472 | 631 | 448 | 609 | -108 |
| Other Working Capital | 2,465 | 410 | -2,462 | 706 | 562 |
| Other Operating Activity | -55 | -373 | -343 | -378 | 432 |
| Operating Cash Flow | $-16,041 | $-10,685 | $-6,598 | $-13,316 | $-9,507 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -15 | N/A | N/A | N/A |
| Net Acquisitions | N/A | N/A | N/A | 6,144 | N/A |
| Investing Cash Flow | $-15 | $-15 | $N/A | $6,144 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 367 | 367 | N/A | N/A | N/A |
| Common Stock Issued | 16,309 | 10,910 | 6,888 | 5,152 | 5,152 |
| Financing Cash Flow | $16,676 | $11,277 | $6,888 | $5,152 | $5,152 |
| Exchange Rate Effect | -10 | -11 | -23 | -6 | -16 |
| Beginning Cash Position | 4,780 | 4,780 | 4,780 | 6,806 | 6,806 |
| End Cash Position | 5,389 | 5,347 | 5,047 | 4,780 | 2,435 |
| Net Cash Flow | $609 | $567 | $267 | $-2,026 | $-4,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,041 | -10,685 | -6,598 | -13,316 | -9,507 |
| Capital Expenditure | -15 | -15 | N/A | N/A | N/A |
| Free Cash Flow | -16,056 | -10,700 | -6,598 | -13,316 | -9,507 |